BioVie Inc.

US$1.33As of Sun 8 Nov 2026, 12:00 UTC
NASDAQ:BIVIHealthcare
Country USA
PE (Fwd) •••
TSR 10Y CAGR (53.32%)
Div yield —
ROE (143.66%)
Biotechnology
Beta (5Y) 0.80
PE TTM —
TSR TTM (24.00%)
Mkt cap US$17.91M
ROIC (89.81%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$1.48
11.18%
(83.13%)
Hold 2|8|7|3|7
2Q26
3Q26
4Q26
1Q27
Earnings per share$
0.02
0.02
0.02
0.02
9.17%
2.80%
(1.28%)
13.84%
Revenue$M
1.441
1.416
1.458
1.508
15.43%
9.96%
8.33%
10.42%
Peers (US$17.91M)
Cap (US$)
PE
Capital
TTM
5Y
10Y
Leveragex
2.786
0.918
0.813
EBIT/Intx
0.210
0.095
0.106
Own earn%
55.51
26.66
30.89
Sh yield%
17.08
41.60
40.55
Owners
Insiders/Inst%
9.32
28.71
Short interest%
4.98
SBC / revenue%
5.94
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
15
Op margin range%
8–15
$1 testx
—
Incr. ROIC%
6